Mr. Aditya Sharma joined Unitus Seed Fund in 2016 to help lead the firm’s investing operations in India. In his professional career spanning over 25+ years, Aditya has served in leadership responsibilities in prestigious global firms such as McKinsey, JP Morgan Chase & Capital One across the US, Europe, Asia and Australia.  He also brings in rich and successful entrepreneurial and investing experience - having served as Managing Director & Member of Global Management Committee at Williams Lea (acquired by Deutsche WorldNet for $1B), Co-Founder of The Whitefield Group (part of Born Group) and Managing Director at eVentures (the 1st seed investor to back MakeMyTrip - Nasdaq IPO MMT, NetMagic - acquired by NTT Communications for $370M+, CustomerAsset - acquired ICICI OneSource, Mentorix - acquired by Nasdaq listed Lionbridge and Intigma - acquired by Emptoris & later by IBM).

Amit Gupta is the Chief Operating Officer of Jupiter Capital, a leading Investment and Financial services firm headquartered in Bangalore with a current portfolio mix that includes Media & Entertainment, Hospitality & Wellness, Aerospace & Engineering services, E-learning, Automobile Technology & E-Commerce.

Prior to joining Jupiter Capital as its Chief Operating Officer, Amit had a stint at Nova Specialty Surgery as Director – Mergers & Acquisitions. Amit is now responsible for JC’s managed investments and there accelerated value creation. In addition, he focusses on identification of new opportunities and nurturing them as an investor representative.

At Jupiter Capital, Amit is the Chief Operating Officer driving accelerated value creation for its investment companies and identifying new investment opportunities across industries. Amit’s experience spans over 19+ years in the field of Finance, Transaction Advisory, M&A, Business Development & VC. His functional expertise includes financial and business strategy, mergers and acquisitions, accelerated value creation, monetization and dealing with diversified demographics.

At Ernst & Young, Amit was Director - Transaction Advisory services where he led large and complex assignments including the Bharti acquisition of Zain and Warid Telecom, Aegis acquisition of PeopleSupport, the i-gate acquisition of Patni, the and nearly 100 other transactions in the IT and ITES space.

In his earlier role as Vice President, GENPACT (GECIS), Amit donned many leadership roles in Finance and General Management with stints across Ireland, England and Australia. He played a critical role in many of GENPACT’s acquisitions and also the company’s NYSE listing in 2006/07. Amit led the setting up the controllership and finance functions for new regions / poles as the assistant global controller at GECIS.

Amit is a qualified CA, CPA from Denver, Colorado with an executive MBA from Wharton Business School, University of Pennsylvania. Outside of Jupiter, Amit is an avid sports enthusiast and enjoys running and kick boxing. On the softer side he enjoys singing and cooking.

Anupam Verma is one of the veterans in the field of healthcare delivery business in India with over 25 years of experience in the domain. Consequently, he has developed an expertise for a broad spectrum of areas, from micro elements of functional process management, to macro issues of creating and managing businesses including Mergers, acquisitions and exits. A Management Graduate by education, and a firm believer in out-of-the-box thinking, he has to his credit several radical and innovative concepts, which have shaped the way the healthcare delivered in the country. He is one of the pioneers in  Healthcare professionals  to have explored the space of Venture Capital and Private Equity for Hospitals. Currently he manages  the countrywide business of Wockhardt Hospitals Ltd., as its President  since 2013. Prior to this he was the founder CEO of DM Healthcare (Aster) in India for 6 years, and Director of Operations at Hinduja Hospital, and CEO at Hinduja Healthcare in Mumbai for 11 years.

Dr. Ajaikumar is a doctorpeneur and the Chairman & CEO of HealthCare Global Enterprises Ltd with over 40 years of experience. After completing his MBBS from St John’s Medical College, Bangalore, he went on to complete his residency training in oncology from the University of Virginia Hospital in Charlottesville followed by fellowship in radiation and medical oncology from the renowned MD Anderson Hospital in Houston, Texas. Dr. Ajaikumar also founded a not-for-pro?t hospital in Mysore, Bharath Hospital and Institute of Oncology in 1989. At the same time, along with a group of oncologists, he started the Bangalore Institute of Oncology (BIO).

HCG was instrumental in introducing high-end technologies like CyberKnife™ and TrueBeam™. It also brought in advanced bone marrow transplant therapies as well as molecular imaging. Dr. Ajaikumar acquired Triesta, which was a molecular diagnostic lab. Today, HCG is rapidly expanding and will soon have 26 comprehensive cancer care centers from its present number, 17. Among his other achievements, he has been awarded the prestigious E&Y Start-Up Entrepreneur of the Year Award as well as the Asian Health Care Leadership Awards. Harvard Business School has done several case studies on HCG. Apart from his charitable work, he enjoys being a marathon runner and is a voracious reader.

@BSAjaikumar_HCG

Dr. Rao studied medicine in Davangere, followed by surgical training at St John's Hospital (Bangalore) and Apollo Hospital (Chennai). After getting his MBA in Boston, he led initiatives to improve the quality of care and clinical effectiveness at pioneer institutions like Massachusetts General Hospital in Boston and Stanford Hospital in California. Syncremedies is his earnest effort to find all the knowledge that is out there and bring it to the patient.

Dr Avasthi founder of Surya Hospitals is a MD in paediatrics and has been a professor and teacher for many years. Currently he runs a 170 bed hospital in Mumbai and 110 bed hospital in Pune catering specifically to woman and child care segment. By March 2017, Surya Hospitals plans to expand further and open up branches in Jaipur and Thane.

Dr Avasthi is actively involved in a  PPP project with corporation in Mumbai and heads the largest neonatal centre in the country. He was the founder and chief of department of paediatrics at Leelavati Hospital in Mumbai.  

Chandru has over 25 years of experience in leading and managing bio pharmaceutical businesses across diverse geographies and segments. An alumnus of IIT Mumbai and IIFT New Delhi, he has a proven track record having managed P&Ls and Strategy and Business Development globally. His varied experience straddles start-ups, acquired companies and multiple product segments. In his last role as SVP – International for Lupin, he headed business operations spread across emerging markets in Asia, Latin America and Africa with directorial responsibility in 5 subsidiaries. Prior to this, Chandru has worked with Wockhardt as General Manager for emerging markets.

Chandru championed the creation of a business and innovation incubator called Cipla New Ventures (CNV), where it is nurturing in venture style, businesses that require unique entrepreneurial and start up like eco systems. Cipla Health was recently spun out as a FMCG style consumer health company with a Series A investment from a marquee investor, Fidelity. CNV is actively exploring the digital health space and looking to support start-ups that can bring true disruption in the areas of bridging the health infrastructure gap, empowering the patient and making physician and patient lives simpler.

Chinta Bhagat is the country head of India and co-head of global healthcare for Khazanah Nasional, the sovereign investment holding company of the government of Malaysia. In his India role, he oversees investments across public and private markets, and across sectors like healthcare, technology, consumer products, and financial services. In his healthcare role, he oversees Khazanah’s holdings in IHH, the world’s second largest health services company by market capitalisation. Chinta is a board member at IDFC, Parkway Pantai Healthcare, and other portfolio companies. Prior to joining Khazanah, Chinta spent 14 years at McKinsey & Company in Singapore, including six years as Managing Partner for the Singapore office. Chinta was a leader in the Principal Investor practice, serving several sovereign investment firms, private equity firms, and family owned businesses; as well as a leader in the Healthcare practice, serving hospital systems across Asia. Chinta also founded and led McKinsey’s corporate governance service line. Prior to joining McKinsey, Chinta held various positions at an engineering and construction firm in India, culminating in his role as CEO. Chinta has an MBA from INSEAD Business School and is a qualified architect.

Dhruv Suyamprakasam is the Founder and CEO of iCliniq.com, an online doctor consultation platform with a user base comprising more than 1,500 doctors from over 80 specialties and 1,20,000 patients spanning 160 countries. The idea was born out of a personal requirement that Dhruv experienced after struggling to find a doctor due to geographical limitations and thus founded iCliniq alongside Dr. Madhan to fill this gap in the market.

As an entrepreneur, Dhruv has worked tirelessly to build the category of online doctor consultations and grow the business. This has resulted in iCliniq being rated as the 5th best telemedicine company in the world by Healthline. It has also been rated as 4th best in Online doctor services by Treato due to popular reviews. The week magazine in 2014 named Dhruv as one of the healthcare innovators in India. Dhruv has a Bachelor’s in Mechanical Engineering from the prestigious College of Engineering in Guindy. Dhruv is passionate about building a start-­-up ecosystem in Coimbatore and is a part of Coimbatore startup group helping young entrepreneurs realize their dreams of entrepreneurship in Coimbatore.

@DhruvaKumar

Mr Gautam Khanna is the CEO of the PD Hinduja Hospital and Medical Research Centre, Mumbai - India. He is also the Head of Hinduja College of Nursing, Mumbai - India. He is responsible for leading the growth of Healthcare Vertical for the Hinduja Group in the Country. He is an independent Director in a healthcare organization and a Governing Council invitee for a few other organisations.Prior to this role, Mr. Khanna was the Executive Director and Country Business Leader of the 3M Health Care businesses in India and Sri Lanka. Mr. Khanna has over 26 years of industry experience and had been working with 3M for more than 22 years internationally and in India.

Mr. Khanna is an active member of industry associations. He was the Chair of the FICCI medical Device Forum, Chair of India working Group, Advamed and a Member of CII National Committee on Healthcare.Currently he is the Vice President for AOH [Association of Hospitals, Maharashtra - India]. He is a founder member of Nathealth and has been leading policy advocacy for the industry in multiple avenues. Mr. Khanna is a MBA from IIM Calcutta and a B Tech in Mechanical Engineering from IIT Kanpur.

Karthik leads operational due diligence and post investment operational value creation at SeaLink Capital Partners (SCP).  He also leads Healthcare investments for SCP.

Prior to co-founding SCP, Karthik was a Principal with KKR Capstone operating out of the Hong Kong and Mumbai offices, where he was involved with operations improvement projects across investments in India. He also co-led KKR’s Green Portfolio Program across Asia, and focused on driving profitable environmental programs in KKR's portfolio companies. Prior to that, Karthik was a Case Team Leader with Bain & Company in India where he was part of the founding teams of the New Delhi and Mumbai offices and focused on performance improvement, private equity due diligence and organization restructuring. He has also spent time with Goldman Sachs Investment Partners in Mumbai and with Capital One Financial in Richmond, Virginia.

Karthik holds a Bachelor of Technology in Computer Science and Engineering from Indian Institute of Technology, Bombay.

Kaustav Ganguli is a Senior Director with Alvarez & Marsal and leads the healthcare practice for the firm in India and the Middle East. Mr. Ganguli has more than 14 years of experience in consulting and industry across the healthcare and life sciences sectors. Till date, he has advised on more than 50 engagements across the healthcare value chain, spanning hospitals, single specialty models, outreach models, diagnostics, pharmacy, health IT, health education, medical equipment and devices and health insurance.

Over the last decade, Mr. Ganguli has advised several large international organizations on their India entry as well as many leading domestic organizations on opportunities related to expansion, diversification and growth. Additionally, he has helped several organizations improve their operational performance and advised on several transactions in Indian Healthcare. Mr. Ganguli earned his engineering degree from Jadavpur University and completed his MBA from SP Jain Institute of Management and Research.

@kausty77

@kanavkahol

Kiran is the founder and CEO of Drishti, an eye hospital chain working to provide affordable eye care in underserved markets. Drishti currently covers several districts in rural Karnataka. He is a telecom engineer and prior to Drishti was a founding member of OnMobile, a company spun out of Infosys.  He helped build OnMobile from a 10 people startup to 1200 people with revenues over 550 crores. He was also a Volunteer – Technology at UIDAI. He is passionate about building Drishti into an sustainable, social impact institution.

Madhur Verma is the CEO of Sahyadri Hospitals Ltd, Maharashtra’s largest chain of multi specialty hospitals with 11 hospitals of 1,300 beds each. Their hospitals are located at Nashik, Navi Mumbai, Pune and Karad.

Prior to this, Madhur was the VP-Operations with Columbia Asia for over six years. Besides Columbia Asia, Madhur has also worked with IVEN Medicare (ICICI Venture) as AVP, with Max as Head-Business Support as well as Escorts and Medwin.

Cofounder and CEO of Bigdecisions.com, a personal finance advisory platform. Started in 2013, was acquired by News Corp in 2014 becoming one of the country's earliest exits to a global corporation. Currently responsible for putting together an organization that helps Bigdecisions become one of India's most robust and transparent platforms.

Prior to starting up, spent 15 years in the financial services industry across markets in India and the US in businesses ranging from unsecured lending, mortgages, wealth management and Life Insurance. Assignments range from managing P&Ls involving large distribution teams spanning widespread geographies to running institutional business development efforts with specialized units.

Manish is an alumnus of IIM Ahmedabad

@ManishAShah26

Milind Godbole is the Managing Director at GeBBS Healthcare Solutions, a leading national provider of revenue cycle management (RCM) and health information management (HIM) solutions for United States of America clientele. With a Master’s degree in Electronics Engineering and an MBA with specialization in Sales and Marketing, Milind Godbole has a proven track record of turnarounds, helping businesses move away from challenging situations, turning the loss making businesses positive, and helping business grow off their current platforms using Software and Technology as an enabler.

In his past role as the President and COO in prestigious global firms such as Mphasis and Aditya Birla Minacs, he headed business strategies and overall corporate performance spread across various industries in the US, Europe and India.

Today, under his leadership GeBBS has witnessed an overall organizational growth and transformational product strategy play. He works closely with client organizations to ensure that they receive optimal value from GeBBS’ solutions. He is also one of the 6 visionaries identified as the 'India 6 (I6)' think-tank for the IT and ITES industry in India.

@MilindGodbole

Monika is a founding partner at Arete Advisors and leader of the healthcare practice. She has c.16 years of consulting experience including over 13 years in healthcare advisory. During this time Monika has worked with more than 100 leading firms, private equity funds and government departments. She has supported them in improving access to healthcare services, formulating strategies for growth, improving operational performance, making investment decisions and building their people’s capabilities. She has provided advisory services across over 50 markets in the country and other South East Asian and Middle Eastern countries. She has an in-depth understanding across sub-segments in healthcare delivery including multi-specialty hospitals, specialty centres and day care, retail formats of healthcare delivery and laboratory and radiology diagnostics.

At Areté she has advised leading healthcare groups in the country and led commercial diligence/post-investment performance improvement exercises for leading global and Indian Private Equity players with interest in healthcare.

Prior to founding Areté, Monika was the President and CEO of the Corporate Advisory Division at Feedback Infra. She is a management graduate from IIM Ahmedabad and a post graduate in Physics from Delhi University.

Mukesh is the Co-Founder and Managing Director of Menterra. Till recently, he was a Chief Investment Officer at Villgro, India’s oldest and foremost social enterprise incubator. He has over 10 years of experience in impact investing, private equity and investment banking space. He has worked on over 50 buy-side and sell-side transactions across Asia, Middle-East and Europe.

Mukesh is also a non-executive director on the board of Biosense Technologies, a company that produces low-cost, non-invasive diagnostic solutions for the developing world. ?He is a Chartered Accountant and has passed all three levels of CFA from CFA Institute, USA.

Dr Mahipal. S. Sachdev, Chairman & Medical Director of Centre For Sight was honored with Padmashri award on January 26, 2007. He is a renowned ophthalmic Surgeon who is recognized for his expertise in the area of  Cataract and Refractive  Surgery, both nationally and internationally. He has a penchant for emerging technology and is a leader in adopting world class technology to the Indian Ophthalmic space. He holds the distinction of having performed the maximum number of femtosecond assisted bladefree cataract surgeries in the country.

He pursued his medical education at the graduate and post graduate level at the prestigious All India Institute of Medical Sciences. He later joined AIIMS as a Faculty Member. In the year 1989 on a sabbatical from the AIIMS and to master the latest in eye care, he took up a Fellowship at Georgetown University, Washington DC, USA for a year and then returned to AIIMS. Upon his return he pioneered the technique of phacoemulsification stitchless cataract surgery in India.

He has authored over 5 books on cataract & Refractive surgery including the first book on phaco by an Indian Ophthalmologist. These books are today referred to by every budding Ophthalmologist.

Nitish Agrawal is a Managing Director at Indium, a healthcare focused investment banking advisory firm. Based in Bengaluru, Nitish has advised on domestic and cross border M&A as well as equity fund raising transactions across all segments of healthcare including large hospital chains, single speciality formats (maternity, IVF, etc), diagnostics, medical devices, and healthcare-tech with a cumulative experience of evaluating over 35+ deals in healthcare.

Nitish has had over 17 years of leadership experience in the past across Allegro Capital, GE Capital & Genpact. He is an engineer from IIT, BHU and holds a Post Graduate Diploma in Management from IIM Calcutta.

Dr. Om Manchanda is the Chief Executive Officer of Dr Lal PathLabs Ltd. He is alumnus of IIM Ahmedabad. Om has over 26 years of work experience. After graduating from the IIMA in June 1990, Om joined Unilever Group Companies (now Hindustan Unilever) as a management trainee. He worked for HUL for nearly 10 years in various positions such as Area Sales Manager, Innovation Manager - Beverages, Senior Brand Manager and Business Manager.

After HUL, he moved to an American company Monsanto India Limited as their National Marketing Manager and thereafter as their National Sales Manager in 1999. Early 2003, He joined Ranbaxy Laboratory Limited in their Global Consumer Healthcare Division and worked initially as General Manager - Marketing and then General Manager - International & Innovation before joining Dr Lal Pathlabs in October 2005.

He has successfully led the transformation of Dr Lal PathLabs in the last 11 years from a family run business to a professionally run listed company. In Dec. 2015, Dr Lal Pathlabs had a blockbuster listing on National Stock Exchange.

Om is the recipient of many awards. Notable ones are CAME innovation awards in HUL, Achiever of the Year Award in 2014, presented by CEO India as a part of CEO Awards 2014. Also the finalist in EY entrepreneur of the year 2015 awards.

@OmManchanda

Pradeep Dhada’s Netmeds.com, known as India Ki Pharmacy, brought home the highly coveted NDTV Unicorn Award for Health-Tech Start-up of the Year. Prior to launching Netmeds, he paved a tracked record of innovation and achievement by founding and leading companies that operated worldwide and within a range of industries that include hospitality, digital publishing, e-commerce, and corporate wellness.

Growing up in Chennai, he graduated from Loyola College and worked at his family’s pharmaceutical business, Dadha Pharma, Pvt. Ltd, creating a retail distribution chain of more than 1,500 outlets. Then, to further hone his business acumen, Pradeep left the comfort zone of the family business and took positions with the contact centre divisions of Reliance Infocom and Sun Communique. In 2003 he developed the back-office model for an international pharmaceutical company, one of the first global operations of its kind. His latest venture, Netmeds.com, is India’s first e-marketplace offering pharmaceutical and OTC healthcare products across the pan-Indian spectrum. In its first year of business the company has served customers in every state and more than 600 cities.

Prashant leads the Healthcare practice at o3 Capital. He has over a decade of investment banking experience and has advised on several completed transactions encompassing the healthcare domain of hospitals, pharma, CRO, medical technology, diagnostics and retail pharmacy chains.

Prior to o3 Capital, Prashant worked with JP Morgan Chase - debt capital markets team, where he handled the UK and Eastern Europe debt underwriting.

Prem Pavoor is a Partner at Eight Roads Ventures and leads investments in India in the lifesciences and healthcare sectors. He was previously based in the United States with McKinsey & Company’s Pharmaceutical and Medical Products Practice where he advised pharmaceutical, consumer healthcare and private equity clients on areas including R&D, business development, manufacturing optimisation and post-merger integrations.

His patented doctoral thesis work at the Massachusetts Institute of Technology (MIT) and Harvard Medical School focused on enhancing the performance of medical implants. Prem is the recipient of the MIT-OMNOVA award for Excellence in Polymer Research. Prem holds a Bachelor’s degree in Chemical Engineering from the Institute of Chemical Technology (formerly UDCT), Mumbai, a MS and Ph.D. in Chemical Engineering Practice from MIT and an MBA from MIT Sloan.

Dr. Ramesh Byrapaneni is a Cardiologist turned Venture Capitalist. Currently he is Managing Director at Endiya Partners, a venture capital fund that invests in ideas with the potential to change the world across Technology, Healthcare and Consumer Services.As a Venture Partner of Ventureast Tenet Fund, a seed-stage VC Fund consisting of investments across technology and technology-enabled sectors, he invested and is on the boards of OneBreath and SmartRx. He has been actively involved with Nephroplus, a healthcare startup, backed by funding from Bessemer.

With significant managerial and entrepreneurial experience, Dr. Ramesh brings a passion for early stage ventures, commitment to work, business acumen and a complementary rolodex. Dr. Ramesh was Chief of Cardiology and Founder of Medwin Hospital. He served as the President of TiE Hyderabad for 4 years and one of the Founding Directors of Hyderabad Angels. He has also jumpstarted various innovative initiatives like Hyderabad 10K Run (the first to start these 10K runs in the country) and Health Awareness Promotion Project India (HAPPi) Hearts project to prevent Non-communicable diseases (NCDs).

Dr. Ravi Gaur, MD Pathology, is the Chief Operating Officer and Lab Director of Oncquest Laboratories, the largest Molecular Onco Pathology laboratory in India. He has 25 years plus experience in the field of Pathology and Health care management. He brought International recognition to the Indian Healthcare Industry in the form of accreditation from the College of American Pathologists (CAP – USA). Currently he operates over 23 labs, including a super specialty centre in New Delhi with over 500 collection centre’s all over India.

Dr. Gaur is a member of many expert and advisory bodies of the industry. He is a senior member of FICCI National health care Committee. He is a quality expert with vast experience of NABL processes and was one of first India based Indian to be certified as International inspector for quality audits for College of American Pathology (CAP-USA).Before joining Oncquest in 2009, Dr Gaur was heading North & East India division of Piramal and Pathnet India Ltd ( a unit of Gribbles Pathology, Australia) He has served in the Army Medical Corps for about 15 years and holds a rank of Major of Indian Army. He has recently been awarded for excellence in setting up a global standard molecular pathology lab in India by Word Wide Achievers and ASSOCCHAM.

Raghav has been with ChrysCapital since September 2003 and focuses on the pharmaceuticals sector. Previously, he was with the global research division at McKinsey & Company. Raghav received an MBA from Management Development Institute, Gurgaon and a Bachelor's degree in chemical engineering from Baroda University

Rohit M A is the co-founder and Managing Director of Cloudnine Group of Hospitals- India’s leading chain of maternity, women and child care service hospitals. He took charge as the Managing Director of the company after being Executive Director at Cloudnine for 9 years.As part of the founding team he expanded operations from a single hospital in South Bangalore to other locations in Bangalore and now a multicity-chain in Chennai, Gurgaon, Mumbai and Pune with more than 12 units and in the pursuit to setup 10 more units in the coming year.

Rohit has previously served on the Confederation of Indian Industries (CII) Panel of Healthcare for Karnataka. Currently, he is a member of Bangalore Chamber of Industries and Commerce. He graduated through the MPEFB program from IIM Bangalore in 2010, specializing in Entrepreneurship and has over 15 years of entrepreneurial management experience. He has been responsible for leading the entire journey and stake holder management of private equity investors and has attracted investments of over 100 million dollars through marquee investors, in the likes of Matrix Partners, Sequoia Capital and India Value fund having invested in to the company. He was recently conferred as the Dynamic Entrepreneur of the Year 2016 through Entrepreneur India.

Ratan Jalan founded Medium Healthcare Consulting in 2009 driven by an urge to ‘make a difference in healthcare’. Innovation in business models and patient empowerment have been at the core of what he does. Ratan has over three decades of experience across diverse industries and functional responsibilities. He started his professional career in the information technology industry with HCL Technologies and then moved to advertising at Lintas (now Lowe).

Earlier, Ratan was the CEO of Apollo Health and Lifestyle Limited, part of the Apollo Hospitals Group for almost a decade. He created some of the most successful and innovative healthcare formats in the country such as a nationwide network of The Apollo Clinic and The Cradle, South Asia’s first boutique birthing centres. In 1996, as President, Ratan set up India’s first hospital architecture and consulting firm Asian Health Services, a JV with ServiceMaster, a Fortune 500 company. He was awarded the Marketing Impact Award by S P Jain Institute of Management and has been nominated as one of the 50 most influential professionals in retailing. He is an alumnus of IIT Kharagpur and Harvard Business School.

Mr. Banerjee joined Bain Capital in 2008 from McKinsey & Company as part of the founding team of the India office. At Bain Capital, he has led investments in Genpact and Emcure Pharmaceuticals and is actively involved in managing these investments for the firm.

Mr. Banerjee received an MBA from The Wharton School of the University of Pennsylvania. He graduated with an MS in Economics and a BS in Chemical Engineering from BITS Pliani, India.

Sanjeev Vashishta is the Chief Executive Officer of SRL Limited, the largest Diagnostics Company in India having over 330 Labs and 7500 Collection Points. A Fortis Group Company, SRL has the complete range of Diagnostics services including Lab Medicine, Imaging, Clinical Trials, Companion Marketing and Wellness and has a very committed team of 6200 employees including 700 Doctors / Scientists. Sanjeev is instrumental in turning around the Company. He has successfully managed to drive the profitability margins 2.5x and taken the EBITDA numbers 4x in less than four years of his association with SRL.

Prior to joining SRL, Sanjeev worked in Fortis for over 6 years where he successfully ran Hospitals. Previously he spearheaded the Mergers & Acquisition function for Fortis where he successfully expanded Fortis presence to all parts of India and also led International acquisitions. He has a unique distinction of running businesses both on the Healthcare delivery (Hospitals) and Diagnostics side.Sanjeev has been associated with various business / professional bodies like FICCI, CII, NHRD network and NATHEALTH etc. A graduate (B.Com Hons.) from Delhi University, Sanjeev is a qualified ‘Company Secretary’ and also done Masters in ‘Business Administration’.

Shantanu Rastogi works from General Atlantic's Mumbai office where he focuses on investments in the Internet & Technology, Emerging Markets Consumer and Healthcare sectors in India. He serves on the board of directors of And Designs India Limited.

Prior to joining General Atlantic, Shantanu was a Principal at Apax Partners. Previously Shantanu was a consultant at McKinsey & Co. in Mumbai. Shantanu graduated from the Indian Institute of Technology and completed his M.B.A. at the Wharton School.

Siddharth Dhondiyal, a Director in the IVFA investment team joined IVFA in 2006 and is involved with investments in healthcare, consumer and technology sectors.   Based in Bengaluru, he contributed to improving IVFA’s internal processes and developing the “The IVFA Way” - the Firm's approach to building admired businesses.

Over the last 10 years Siddharth has focused on tracking the evolution and growth of the Indian healthcare sector and has been actively involved in IVFA’s investments in the healthcare sector including Aster DM Healthcare, Manipal Hospitals, Trivitron Healthcare and Cloudnine Hospitals.

A Bachelor of Mechanical Engineering from IIT, Kanpur, Siddharth also holds a Post Graduate Diploma in Management from IIM, Kolkata and did his Masters in Business Administration from INSEAD, France.   He had a six-year stint with Accenture in its strategy consulting practice, where he worked with companies in the pharmaceutical, consumer goods, industrial products and telecom industries.

Sohil brings to NVP India more than 13 years of financial, investment banking and private equity investment experience from leading global financial institutions. Based in the NVP India Mumbai office, Sohil serves as an advisor on growth equity investments in Indian companies across a wide range of sectors, including telecom, technology, financial services, infrastructure and manufacturing. Sohil advised NVP India’s investments in Asian Genco Pte Ltd. (AGPL), NSE (National Stock Exchange of India, Ltd.), Nueclear Healthcare Limited, Sadbhav, Snowman Logistics, and Thyrocare. Sohil is also a board observer for NationWide Primary Healthcare Services.

Prior to joining NVP India, Sohil was an Executive Director in Goldman Sachs’ Asian Special Situations Group, a balance sheet investing group with over $4 billion under management. Sohil was the first executive recruited for the group’s India business in 2006 and became part of a five-member team in Mumbai tasked with building and running the India business. In this role with Goldman Sachs, Sohil was involved in making over $300 million of private equity and PIPE investments in India.

Sumit joined IVFA in 2016 and is based out of Mumbai. He is closely involved in supporting and building IVFA companies across different sectors including healthcare, consumer goods, agri and industrial services, etc. He is a Mechanical Engineer from Pune and has a Post Graduate Diploma from Indian Institute of Management, Kolkata.

Prior to joining IVFA, Sumit was a Principal with Bain & Co. where he supported several domestic & multinational firms across sectors including industrial goods & services, textiles, chemicals, infrastructure, health care, consumer goods dealing with growth strategies, operational efficiency, cost reduction, organization effectiveness, etc. Before Bain, he helped set up an engine manufacturing plant for the Kirloskar Group and implement lean systems across their operations. Earlier, he worked with J&J Medical, where he managed the sales of cardiac.

Tarun joined NEA's India office in 2009 and is a Director of New Enterprise Associates (India) Pvt. Ltd. (NEA India) based in Mumbai. Tarun brings more than twelve years of experience in various roles in private equity investing and equity research. He serves as Director on the board of Nova Medical Centers, Air Works Engineering and Infinitas Renewable Energy Solutions and and as Board Observer on the boards of inTarvo Technologies and Intellisys Technologies. Prior to joining NEA, Tarun was with Peepul Capital Private Equity, where he evaluated investment opportunities across sectors including consumer products and services, education, manufacturing and media. He was involved in structuring and executing transactions and actively managed portfolio companies in consumer and media sectors. Previously, Tarun worked at Goldman Sachs International based out of their London offices, initially with the Equity Derivatives team, and then as part of the Global Macro Proprietary trading team. Tarun received an MBA from the Indian Institute of Management (IIM) Ahmedabad, India and earned his B.Tech. degree in Mechanical Engineering from the Indian Institute of Technology (IIT) at Delhi, India.

A visionary and an able business administrator, Dr. A. Velumani proves amply clearly to industry that, 11 Focus gives Success". Born to a landless farmer in a small village near Coimbatore, South India, today he owns and operates Thyrocare, an industry leader and a brand worth over Rs. 3000 crores. Began as a mathematician, he acquired his Ph.D in Thyroid Biochemistry from BARC / Mumbai University. He worked for 14 years in BARC as a Research Scientist and Teacher and then became an administrator in business.

He is Chairman and Managing Director of Thyrocare Technologies Limited, a pathology vertical and CEO of Nueclear Healthcare Limited which is a Radiology vertical. His focus areas are Thyroid Biochemistry, Bioanalytical Chemistry, Nuclear Chemistry and Nuclear Medicine.

An infectious motivator, he has succeeded in converting educated as employed, graduates as professionals, individuals as entrepreneurs, vendors as partners, family members as wealth creators and by his unique way, transformed intimidating problems into opportunities.

He is hilarious when it comes to educating and motivating youth in Entrepreneurship.

@velumania

Vamesh joined Tata Capital in March 2015 as Partner of the Tata Capital Healthcare Fund. He has over 25+ years of experience in investment banking and private equity advisory. His experience spans managing investments and advising businesses across multiple industries. Vamesh co-lead’s the healthcare fund team and will be actively involved in managing the full lifecycle of new fundraising, investing, portfolio management and divestments.

Vijay Nallan Chakravarthi is an Executive Director at Standard Chartered Private Equity (SCPE), where he leads investments in Financial Services, Healthcare, Consumer, Technology and Education sectors. He is involved with the fund’s investments in Fortis, Cafe Coffee Day group and Varun Beverages. Prior to SCPE Vijay was a Vice President at Bain Capital India and at The Boston Consulting Group (Chicago), where he focused on private equity and M&A. Vijay is also a certified Six Sigma Black Belt and alumnus of the Operations Management Leadership Program from the General Electric Company (GE, USA), where he held multiple leadership positions in GE’s healthcare business .

Vijay earned an MBA from the Kellogg School of Management, MS from The Ohio State University and BE from the University of Madras.

Vikram Kumar brings 15 years of experience in analytics delivering unusual results for companies as Microsoft Corporation, Apollo, Manipal Hospitals and 6 of India's 9 largest hospitals in addition to largest chains of Africa and Middle East. He is co-founder and CEO of Multiplier Solutions, a leading healthcare analytics solutions company that over 5 years has delivered over USD 10 million of incremental revenue to leading healthcare firms. Vikram is an MBA from IIM Calcutta and engineer from IIT-BHU post which he worked as 1st employee of indya.com which he helped launch what became a $50 million investment from Rupert Murdoch and brief stint at ANZ investment bank where he helped used analytics to develop new models for financing.

After a decade delivering advanced predictive analytics solutions for global marketing operations of Microsoft USA, he had an accident that shifted his interest to healthcare, Over last five years his team has helped leading healthcare firms develop advanced disease prediction models and leverage newer technology as machine learning, big data to deliver next generation of personalized patient care. Multiplier Solutions was founded 5 years ago and has 35 employees. It is angel funded by international investors.

Vikram Utamsingh is Co-Head of A&M India and a Managing Director with Alvarez & Marsal’s Transactions Advisory Group in Mumbai. He brings 20 years of experience in Indian mergers and acquisitions. His primary areas of concentration are due diligence services and corporate finance services.

He has worked with clients across a range of industries, including industrial, consumer and private equity. Mr. Utamsingh’s areas of expertise are analyzing quality of earnings, evaluating cash flows in terms of key business drivers, analyzing strengths and weaknesses of balance sheets, identifying related-party and unusual transactions, accounting for mergers and acquisitions, reviewing purchase and sale agreements and assessing compliance with Indian GAAP and IFRS.

Before joining A&M, Mr. Utamsingh spent 15 years with KPMG India Private Ltd., where he held several leadership positions. He established and led the Transactions Due Diligence practice from 2004 to 2009 and the M&A Strategy practice from 2007 to 2009. Most recently, he served as the Head of Transactions and Restructuring overseeing the due diligence business, M&A strategy business, valuations business and the corporate finance business.

Key accomplishments include: achieving a leadership position in M&A transactions, working on 100 PE transactions in 2012; helping KPMG’s corporate finance business to advance in 2012 to a number-two ranking in Thomson Reuters’ Indian M&A league tables; and building the largest M&A strategy business group serving both private equity and corporate clients. In addition, he published a detailed assessment of Returns from Indian Private Equity transactions in 2011, and he has provided transaction services to more than 50 private equity clients.

Mr. Utamsingh earned a bachelor’s degree in commerce and accounting from Sydenham College of Commerce and Economics and is a dual Chartered Accountant from the Institute of Chartered Accountants in England and Wales and the Institute of Chartered Accountants of India. He is a member of the Institute of Directors in the U.K. and is fluent in English and Hindi.

Vikram Vora is the Co-Founder and CEO of Mydentist, India's largest chain of dental clinics. Mydentist owns and operates 112 dental clinics across 7 Cities, which are company owned and have a centralized management/ procurement process.  With a mission of making dental treatment affordable and accessible for all, Mydentist has treated more than 600,000 patients in a span of less than five years. Mydentist has total staff strength of over 1400 people, which included over 500 dentists.

Vikram has a Bachelor’s in Production Engineering and a Masters in Management Studies both from the Mumbai University. Among his recognitions and awards, he has been recognized as one of 100 most creative people in the world by Fast Company in 2014;  awarded the TiE Lumis Entrepreneurial Excellence Award 2013; awarded the VCCircle Healthcare Award in  2014  for Emerging Healthcare Company of the Year for Mydentist; featured on list of hottest young entrepreneurs by Business World in 2013 and featured on the list 11 Startups to watch for in 2012 by Forbes India.

@vora_vikram

Vishal Bali brings with him 24 years of experience in building and leading global healthcare delivery organizations through organic and M&A driven strategic growth initiatives across Asia Pacific. His experience of managing a billion dollar integrated healthcare delivery organisation comprising Hospitals, Diagnostics, Primary Care and Daycare Speciality in diversified geographies of India, Australia, New Zealand, Hong Kong, Singapore, Vietnam, SriLanka and Dubai has given him the exceptional opportunity to transform healthcare businesses in both developing and developed countries.

Vishal is currently Asia Head - Healthcare , TPG Growth which is amongst the leading private equity firms globally. He is also Co -founder & Chairman of Medwell Ventures, India.

Prior to his current assignment Vishal was the Group CEO for Fortis Healthcare Limited. His earlier roles also include CEO for Fortis Healthcare International in Singapore and CEO for Fortis Hospitals in India. His past assignment also includes spearheading the growth and transformation of Wockhardt Hospitals from a single hospital to one of India’s largest speciality hospital chains as its CEO & Managing Director. His expertise in integrating healthcare strategy with operations and management has set industry benchmarks. He sits on the board of leading healthcare organisations and has been an invited member of the Strategic Initiatives group of Joint Commission International, US and a past member of the Global Agenda Healthcare Council of the World Economic Forum. Vishal Co-Chairs Healthcare Services for Federation of Indian Chamber of Commerce and Industry.

Dr. Desai is the Founder Director of HOSMAC India, is a renowned name in Hospital Planning & Management field in India and abroad. In his consultancy career spanning more than a decade, Dr. Desai has advised more than 500 hospital projects in areas of feasibility studies, market research, hospital planning and management consultancy in India and abroad. He is a visiting faculty to premier institutions like Tata Institute of Social Science, IHMR Jaipur, IIT Mumbai, Welingkar School for Management, All India Institute of Local Self Government, etc. Apart from this, he has worked as an Advisor to numerous multilateral agencies like the World Bank, UNICEF, WHO, IL&FS, Ministry of Health and Family Welfare etc.

For his accomplishments, he was selected as ‘Leader of Tomorrow’ by ET NOW business news channel in the Healthcare and Bio-Technology category in the year 2011. He has been invited on prestigious industry forums like FICCI, Indian Merchant Chambers and CII as a special invitee to chart out various policy guidelines for growth of the healthcare industry in India.